Search results for "ffpe challenges"
Selected Filters:
Novel diagnostic assay for gastric and gastroesophageal junction cancer receives CE Mark approval
Roche obtains CE certification for VENTANA CLDN18 (43-14A) RxDx Assay to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY
Unlocking the potential of the multi-attribute method (MAM): The future of biopharma
New eBooks by Waters Corporation reveal the capabilities, adoption trends, and future of MAM for biotherapeutic analysis
Cellular decision making in normal and leukemic blood stem cells
This guest editorial explores how advances in single-cell technologies to reveal novel insights into hematopoietic development
CytoSections: Validated Control for IHC, ISH, ICC
OriGene TechnologiesCytoSections is a verified, reproducible, and renewable positive control source where the target protein's expression is confirmed by western blot and IHC.
How to overcome the RNA delivery dilemma
Cancer study emphasizes the need for non-targeted PFAS analysis
Non-targeted analysis (NTA) testing can help reveal the hidden dangers of 'forever chemicals’ following findings linking PFAS exposure to thyroid cancer
High-resolution sampling 2D-LC for pharmaceutical impurity analysis
NexION® 2000 ICP Mass Spectrometer
PerkinElmerNexION 2000 ICP-MS – Triple-quad power meets single-quad versatility
Simplify volatiles analysis (Part 1): Why adopt direct MS in your lab or CRO?
Join us on Tuesday, September 15, for part one of the Syft Webinar Series on selected ion flow tube mass spectrometry
MSACL testimonial from Dr. Ian Lewis
Robust LC-MS workstream for toxicology analysis
Atomic force microscopy for materials
Water needs in pharma quality control
How novel technologies are driving our understanding of the complex and dynamic nature of the human cell
SSci_CT_Manuel_Leonetti_Feb22_166_V2.txt
A simple quantitative method for monoclonal antibody coformulations
Sysmex and Hitachi High-Tech agree to collaborate on development of new genetic testing systems
Collaboration aims to expand optimal genetic testing for individual diseases
Alzamend Neuro's AL001 formulation highlights its potential to treat disorders such a Alzheimer's
By potentially removing the requirement for lithium therapeutic drug monitoring (TDM), AL001 could transform treatment for at-risk patient groups and enhance clinical outcomes
Wolters Kluwer introduces Ovid Guidelines AI, transforming clinical guideline development with agentic AI
Ovid Guidelines AI set to accelerate ASCO guideline research workflow with GenAI

















